DrugApr 13, 2016
Bio-pharm Ranitidine Syrup recall — FDA D-0809-2016
Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.
Class IIIFDA: TerminatedBio-pharm, Inc.
Recall history in this database
Classification mix: Class III: 1, Class II: 1.
DrugOct 29, 2014
Bio-pharm Rugby Children's Pain and Fever Acetaminophen Oral Suspension 160 mg/5 mL, Cherry recall — FDA D-0028-2015
Superpotent Drug: Bio-Pharm, Inc. is initiating a recall of one lot of Acetaminophen Oral Suspension Liquid 160mg/5mL failure of the product assay at the 6 month timepoint.
Class IIFDA: TerminatedBio-pharm, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Bio-pharm, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.